{"id":"https://openalex.org/W114111197","doi":null,"title":"The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients.","display_name":"The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients.","alternate_titles":[],"publication_year":1988,"publication_date":"1988-01-01","ids":{"openalex":"https://openalex.org/W114111197","mag":"114111197","pmid":"https://pubmed.ncbi.nlm.nih.gov/3219687"},"language":"en","primary_location":{"id":"pmid:3219687","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3219687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W114111197"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"D Robinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Robinson","raw_affiliation_strings":["Pharmaceutical Research Development Division, Bristol-Myers Company, Wallingford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Development Division, Bristol-Myers Company, Wallingford, Connecticut","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070667576","display_name":"Michael J. Napoliello","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M J Napoliello","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"J Schenk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Schenk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0244,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.75443951,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"10","issue":"6","first_page":"740","last_page":"746"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.014999999664723873,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":1.0},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.8899999856948853},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7390000224113464},{"id":"https://openalex.org/keywords/age-differences","display_name":"age differences","score":0.5830000042915344},{"id":"https://openalex.org/keywords/anxiety-treatment","display_name":"anxiety treatment","score":0.5590000152587891},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5899999737739563},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.6779999732971191},{"id":"https://openalex.org/keywords/hamilton-anxiety-rating-scale","display_name":"Hamilton Anxiety Rating Scale","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.968433141708374},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9299850463867188},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.7790061235427856},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.7548922300338745},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5716844201087952},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.48461875319480896},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39858177304267883},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.27330875396728516},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3219687","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3219687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Journal Article"},{"id":"mag:114111197","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3219687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2033642577","https://openalex.org/W2036719521","https://openalex.org/W1996352277","https://openalex.org/W2400947919","https://openalex.org/W2472367774","https://openalex.org/W2005894226","https://openalex.org/W2023300106","https://openalex.org/W2083473891","https://openalex.org/W25454901","https://openalex.org/W133794067"],"abstract_inverted_index":{"Buspirone,":[0],"the":[1,4,70,82,94,109,129,134,141,145],"prototype":[2],"of":[3,8,53,59,102,116,177],"new":[5],"azaspirodecanedione":[6],"series":[7],"antianxiety":[9],"drugs,":[10],"was":[11],"studied":[12],"in":[13,17,30,121,133,140,164,179],"over":[14],"6,000":[15],"patients":[16,37,75,87,98,119,154],"an":[18],"open,":[19],"multicenter":[20],"trial":[21],"to":[22,49,68,153],"confirm":[23],"its":[24],"safety":[25],"and":[26,81,96,113,173],"usefulness":[27],"for":[28],"anxiety":[29,41,103,178],"a":[31,56],"typical":[32],"medical":[33],"practice":[34],"setting.":[35],"Non-psychotic":[36],"with":[38,55],"clinically":[39],"manifest":[40],"that":[42,139,148],"required":[43],"anxiolytic":[44],"drug":[45],"therapy":[46],"were":[47,65],"enrolled":[48],"receive":[50],"four":[51,105],"weeks":[52,106],"treatment":[54],"fixed":[57],"dose":[58],"buspirone":[60,149],"(15":[61],"mg/day).":[62],"Patient":[63],"data":[64,146],"analyzed":[66],"according":[67],"age:":[69],"elderly":[71,95,135,180],"group":[72,84],"comprised":[73],"605":[74],"aged":[76,155],"65":[77,90,156],"years":[78,91,157],"or":[79,158],"older,":[80],"younger":[83,97,142],"included":[85],"5,969":[86],"less":[88],"than":[89],"old.":[92],"Both":[93],"achieved":[99],"similar":[100],"relief":[101],"within":[104],"based":[107],"on":[108],"Hamilton":[110],"Anxiety":[111],"Scale":[112],"global":[114],"assessments":[115],"improvement.":[117],"Most":[118],"(80%)":[120],"both":[122],"groups":[123],"reported":[124],"no":[125],"side":[126,130],"effects.":[127],"Further,":[128],"effect":[131],"profile":[132],"differed":[136],"little":[137],"from":[138],"patients.":[143,181],"Overall,":[144],"indicate":[147],"may":[150],"be":[151],"administered":[152],"older":[159],"without":[160],"any":[161],"special":[162],"adjustment":[163],"dose,":[165],"does":[166],"not":[167],"cause":[168],"unusual":[169],"adverse":[170],"age-related":[171],"phenomena,":[172],"relieves":[174],"moderate-to-severe":[175],"symptoms":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W114111197","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
